Transaction in Own Shares

Summary by AI BETAClose X

On September 8, 2025, GSK plc, acting through its broker Merrill Lynch International, purchased 219,116 of its own ordinary shares with a nominal value of 31¼ pence each. The lowest price paid per share was 1,446.00 GBp, and the highest price was 1,485.50 GBp, with a volume-weighted average price of 1,460.93 GBp. These shares will be held as treasury shares as part of an existing buyback program. Since June 4, 2025, GSK has purchased 27,811,293 ordinary shares. Following this transaction, GSK holds 245,945,676 ordinary shares in treasury and has 4,069,456,051 ordinary shares in issue, excluding treasury shares; the percentage of voting rights attributable to treasury shares is 6.04 percent.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings